(19)
(11) EP 3 062 792 A1

(12)

(43) Date of publication:
07.09.2016 Bulletin 2016/36

(21) Application number: 14799940.3

(22) Date of filing: 31.10.2014
(51) International Patent Classification (IPC): 
A61K 31/4245(2006.01)
A61K 31/545(2006.01)
A61K 45/06(2006.01)
A61K 31/5377(2006.01)
(86) International application number:
PCT/US2014/063504
(87) International publication number:
WO 2015/066515 (07.05.2015 Gazette 2015/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 01.11.2013 US 201361898971 P

(71) Applicant: Celgene International II Sarl
2108 Couvet (CH)

(72) Inventors:
  • MARTINBOROUGH, Esther
    San Diego, California 92124 (US)
  • BOEHM, Marcus, F.
    San Diego, California 92104 (US)
  • YEAGER, Adam, Richard
    La Mesa, California 91941 (US)
  • TAMIYA, Junko
    Carlsbad, California 92011 (US)
  • HUANG, Liming
    San Diego, California 92129 (US)
  • BRAHMACHARY, Enugurthi
    San Diego, California 92131 (US)
  • MOORJANI, Manisha
    San Diego, California 92127 (US)
  • TIMONY, Gregg, Alan
    San Diego, California 92130 (US)
  • BROOKS, Jennifer, L.
    Encinitas, California 92024 (US)
  • PEACH, Robert
    San Diego, California 92129 (US)
  • SCOTT, Fiona, Lorraine
    San Diego, California 92116 (US)
  • HANSON, Michael, Allen
    San Marcos, California 92078 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)

   


(54) SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND COMBINATION THERAPY THEREWITH